Orchestra BioMed Holdings, Inc. (OBIO) Insider Trading

Name: Orchestra BioMed Holdings, Inc. (OBIO) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Darren Sherman (President and Chief Operating Officer): Sale of 15,000 shares, $95.4K.

Get alerted when insiders trade OBIO

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta